Biotech | August 26, 2021
Adjuvance announce clinical results of its next-gen saponin adjuvant
First results demonstrate favourable tolerability of TQL-1055 at all dose levels
First results demonstrate favourable tolerability of TQL-1055 at all dose levels
Opaganib, a leading novel small molecule investigational oral pill in development for Covid-19, is a unique host targeted, dual antiviral and anti-inflammatory drug that acts on the cause and effect of the disease
The aim is to give a fillip to R&D in the health sector to face the Covid-19 challenge
The foundation has been working closely with the Kidwai Memorial Institute of Oncology on several projects since 2001
Viraleze was developed for application in the nasal cavity to help reduce exposure to respiratory viruses, including SARS-CoV-2. The product is registered for sale in Europe and India, and available online in certain markets
When the Delfi technology was used as a pre-screen to determine if a low dose CT (LDCT), should be performed, the combined approach led to the detection of 90% of lung cancers, including 80% of stage I cancers
The software enables real-time communication between patients, caregivers, physicians, and pharmacists and each cartridge in the device has a unique, traceable serial number registered to the patient
This is the world’s first Covid=19 DNA vaccine developed in partnership with DBT-BIRAC
The funds will be used to buy medicines, enhance oxygen supply and augment the bed capacity in the local and district level hospitals
Rs one crore for each district to create medicine pool and support Centre of Excellence for Telemedicine
Subscribe To Our Newsletter & Stay Updated
